CDEK by Data4ThePeople
Drugs
Search by NameFDA Approval TrendsAdvanced SearchFDA Approved Drugs
Organizations
Search by NameOrganization TrendsAdvanced Search
IndicationsMechanismsTrialsFDA Approvals
About
About CDEKGlossaryAdvanced Search GuideSearch by Name
Drugs
Search by NameFDA Approval TrendsAdvanced SearchFDA Approved Drugs
Organizations
Search by NameOrganization TrendsAdvanced Search
IndicationsMechanismsTrialsFDA Approvals
About
About CDEKGlossaryAdvanced Search GuideSearch by Name
← All indications

Tenofovir

An adenine analog REVERSE TRANSCRIPTASE INHIBITOR with antiviral activity against HIV-1 and HEPATITIS B. It is used to treat HIV INFECTIONS and CHRONIC HEPATITIS B, in combination with other ANTIVIRAL AGENTS, due to the emergence of ANTIVIRAL DRUG RESISTANCE when it is used alone.

Subtype terms (4)

More specific conditions that are subtypes of Tenofovir in the MeSH hierarchy.

  • Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination
  • Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination
  • Emtricitabine, Rilpivirine, Tenofovir Drug Combination
  • Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination

Drugs by status

Phase 4 trials (5)

  • vitamin d3
  • calcium carbonate
  • besifovir
  • tenofovir
  • tenofovir alafenamide

Phase 2 trials (4)

  • lenalidomide
  • dolutegravir
  • emtricitabine
  • chidamide

CDEK

The Clinical Drug Experience Knowledgebase — tracking drugs, sponsoring organizations, and clinical trials from first-in-human testing through approval.

Browse

  • Drugs
  • Organizations
  • Trials

About

  • About CDEK
  • Glossary

Built and maintained by Data4ThePeople.

YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED "AS IS", WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.